Before combining a seller note with an SBA acquisition loan, identify what the note is meant to do. A note proposed as an equity-injection source and a separate paying seller loan create different questions. Do not assume that a short payment holiday gives a note the treatment required for the injection.
Reviewed November 22, 2026. This explanation uses Appendix 15 of SOP 50 10 8.1, effective October 1, 2026. The lender must confirm current policy, applicable notices, transaction classification, and the signed documents. This is a document-review guide, not an approved note or a completed transaction.
For seller debt considered equity under Appendix 15, the debt must be subordinated to the lender and on full standby. That means no principal or interest payments for the term of the 7(a) loan. A two-year delay followed by scheduled payments does not meet that full-term assumption.
The policy distinguishes interest accrual from payment. Interest may accrue on standby debt and be added to the debt for amortization after the 7(a) loan is paid in full. That possibility does not authorize a current interest payment. Read the note, standby agreement, accrual method, maturity, and later repayment schedule together.
Under the baseline Appendix 15 rules, limited equity sources in total may provide no more than half of the required injection. A qualifying full-standby seller note is one such source. The note is not spendable cash. Do not count the same amount both as deferred consideration and as cash available for costs or working capital.
The separate Veteran Business Acquisition notice effective November 11, 2026 permits a different source mix for qualifying transactions without waiving the minimum injection. Have the lender verify the notice's timing, ownership, control, and documentation conditions. Do not assume that every veteran-owned proposal qualifies.
The acquisition financing example separately reconciles $60,000 buyer cash and a proposed $60,000 standby note against an assumed $120,000 injection. Its repayment cases distinguish that full-standby note from a different paying-note scenario. They are fictional arithmetic, not approvals.
A seller on full standby exchanges part of the closing cash for a restricted debt claim. The buyer's forecast does not prove that the seller will be paid later. Review the possible accrued balance, delayed liquidity, priority, enforcement limits, default terms, and the business's ability to fund a later repayment. The seller should evaluate the actual documents with independent advisers.
A seller note that is not counted as equity still needs a separate review of its permitted terms and the transaction's repayment capacity. Do not transfer the full-standby note's equity treatment to a different note that pays currently.
Seller earnouts are not an assumed workaround: Appendix 15 prohibits seller earnouts in covered ownership changes. A general earnout discussion for other acquisitions does not establish that a contingent payment is permitted in an SBA-financed transaction.
No. For the equity treatment discussed here, full standby prohibits principal and interest payments for the 7(a) loan's term.
No. Accrual can increase the balance without a current cash payment. Review the documents and lender requirements before assuming a payment is permitted.
No. Standby, subordination, the business's performance, and the actual documents affect the seller's risk. A repayment forecast does not establish recovery.